MXPA06013537A - 3-??4-{(alcanoil 6- substituidas) piridin-3-il}-3 -fenil!-5-(1h-1, 2, 3-triazol -1-ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos. - Google Patents

3-??4-{(alcanoil 6- substituidas) piridin-3-il}-3 -fenil!-5-(1h-1, 2, 3-triazol -1-ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos.

Info

Publication number
MXPA06013537A
MXPA06013537A MXPA06013537A MXPA06013537A MXPA06013537A MX PA06013537 A MXPA06013537 A MX PA06013537A MX PA06013537 A MXPA06013537 A MX PA06013537A MX PA06013537 A MXPA06013537 A MX PA06013537A MX PA06013537 A MXPA06013537 A MX PA06013537A
Authority
MX
Mexico
Prior art keywords
compound
formula
mmol
pharmaceutically acceptable
group
Prior art date
Application number
MXPA06013537A
Other languages
English (en)
Spanish (es)
Inventor
Michael Barry Gravestock
Fei Zhou
Folkert Reck
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411593A external-priority patent/GB0411593D0/en
Priority claimed from GB0500054A external-priority patent/GB0500054D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA06013537A publication Critical patent/MXPA06013537A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA06013537A 2004-05-25 2005-05-24 3-??4-{(alcanoil 6- substituidas) piridin-3-il}-3 -fenil!-5-(1h-1, 2, 3-triazol -1-ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos. MXPA06013537A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411593A GB0411593D0 (en) 2004-05-25 2004-05-25 Chemical compounds
GB0500054A GB0500054D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002051 WO2005116022A1 (en) 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Publications (1)

Publication Number Publication Date
MXPA06013537A true MXPA06013537A (es) 2007-01-26

Family

ID=34968778

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06013537A MXPA06013537A (es) 2004-05-25 2005-05-24 3-??4-{(alcanoil 6- substituidas) piridin-3-il}-3 -fenil!-5-(1h-1, 2, 3-triazol -1-ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos.

Country Status (10)

Country Link
US (1) US20080021012A1 (enExample)
EP (1) EP1753754A1 (enExample)
JP (1) JP2008500317A (enExample)
AU (1) AU2005247668A1 (enExample)
BR (1) BRPI0511526A (enExample)
CA (1) CA2566963A1 (enExample)
IL (1) IL179349A0 (enExample)
MX (1) MXPA06013537A (enExample)
NO (1) NO20065889L (enExample)
WO (1) WO2005116022A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP2346858B1 (en) * 2008-10-10 2019-08-07 Merck Sharp & Dohme Corp. Methods for preparing oxazolidinones and compositions containing them
UA114068C2 (xx) 2009-02-03 2017-04-25 Кристалічні частинки (r)-3-(4-(2-(2-метилтетразол-5-іл)піридин-5-іл)-3-фторфеніл)-5-гідроксиметилоксазолідин-2-ондиводеньфосфату
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
JP6864379B2 (ja) 2016-03-31 2021-04-28 オンターナル セラピューティック インコーポレイテッドOncternal Therapeutics, Inc. インドール類似体及びその使用
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6689779B2 (en) * 2000-06-05 2004-02-10 Dong A Pharm. Co., Ltd. Oxazolidinone derivatives and a process for the preparation thereof
US7473699B2 (en) * 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents

Also Published As

Publication number Publication date
NO20065889L (no) 2007-02-20
BRPI0511526A (pt) 2007-12-26
JP2008500317A (ja) 2008-01-10
IL179349A0 (en) 2007-03-08
WO2005116022A1 (en) 2005-12-08
US20080021012A1 (en) 2008-01-24
AU2005247668A1 (en) 2005-12-08
EP1753754A1 (en) 2007-02-21
CA2566963A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
US20060058317A1 (en) Oxazolidinone derivatives as antibacterial
EP1446403B1 (en) Aryl substituted oxazolidinones with antibacterial activity
MXPA05005522A (es) Oxazolidinonas como agentes antibacterianos.
MXPA05005651A (es) Derivados de oxazolidinona y/o isoxazolina como agentes antibacterianos.
JP2006512352A (ja) オキサゾリジノン誘導体及び抗菌薬としてのそれらの使用
US20080021071A1 (en) 3-{4-(Pyridin-3-Yl) Phenyl}-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
US20060052399A1 (en) Oxazolidinone derivatives as antibacterial agents
MXPA06013539A (es) 3-[4-(6-{4, 5-dihidroisoxasol- 3-il} piridin-3-il) -3-fenil]-5-(1h-1, 2, 3-triazol-1 -ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos.
MXPA06013540A (es) Derivados de 3-(4-(2 -dihidroisoxasol -3-ilpiridin-5-il) fenil)-5- triazol-1- ilmetiloxazolidin -2-ona como inhibidores de mao para el tratamiento de infecciones bacterianas.
MXPA06013537A (es) 3-??4-{(alcanoil 6- substituidas) piridin-3-il}-3 -fenil!-5-(1h-1, 2, 3-triazol -1-ilmetil)-1, 3-oxazolidin- 2-onas como agentes antibacterianos.
US20060116389A1 (en) Antibacterial oxazolidinones
JP2006520774A (ja) 抗菌性1,3−オキサゾリジン−2−オン誘導体
KR20070023766A (ko) 항박테리아제로서의 3-[4-{6-(치환알카노일)피리딘-3-일}-3-페닐]-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온
CN1989134A (zh) 作为抗菌剂的3-{4-(吡啶-3-基)苯基}-5-(1h-1,2,3-三唑-1-基甲基)-1,3-唑烷-2-酮类
KR20070023765A (ko) 항박테리아제로서의3-{4-(피리딘-3-일)페닐}-5-(1h-1,2,3-트리아졸-1-일메틸)-1,3-옥사졸리딘-2-온
KR20070022784A (ko) 박테리아 감염의 치료를 위한 mao 억제제로서의3-(4-(2-디히드로이속사졸-3-일피리딘-5-일)페닐)-5-트리아졸-1-일메틸옥사졸리딘-2-온 유도체

Legal Events

Date Code Title Description
FA Abandonment or withdrawal